Charles River Laboratories International Inc
(NYSE:CRL)
$
214.2
25.52 (13.53%)
Market Cap: 10.95 Bil
Enterprise Value: 13.50 Bil
PE Ratio: 25.59
PB Ratio: 2.97
GF Score: 87/100 Charles River Laboratories International Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
May 12, 2020 / 03:00PM GMT
Release Date Price:
$160.96
(-2.00%)
Operator
Hello. This webcast presentation is for Bank of America clients only. If you are a member of or representation of the press or media, please disconnect now. And now I would like to turn the call over to the analyst. Thank you, and have a good day.
Juan Esteban Avendano
BofA Merrill Lynch, Research Division - Associate
Thank you. Good morning, everybody. And welcome to the 2020 Bank of America Health Care Conference, Virtual. This is Juan Avendano, the U.S. CRO and CDMO Analyst. And it is a pleasure for me to start this off with Charles River Labs, the leading preclinical CRO. And I am pleased to be joined by Jim Foster, Chairman, President and CEO.
Jim, how are you? Thank you very much
James C. Foster
Charles River Laboratories International, Inc. - Chairman, CEO & President
Nice to be here. Would you like me to start while -- I'm sorry. Go ahead.
Juan Esteban Avendano
BofA Merrill Lynch, Research Division - Associate
Yes. Sounds good. And so maybe, Jim,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot